Enforcement Report - Week of May 31, 2023
Enforcement Report - Week of February 22, 2023
Enforcement Report - Week of April 13, 2022
Amneal`s Generic Methylprednisolone Receives Approval In US
Enforcement Report - Week of August 25, 2021
BOSTON, June 16, 2021 /PRNewswire/ -- When children started getting sick with a multisystem inflammatory syndrome (MIS-C) in the wake of COVID-19, physicians most often turned to two treatments: IV immunoglobulin (IVIG), because of MIS-C's similarities with Kawasaki disease, and steroids such as methylprednisolone because of its inflammatory features.
Enforcement Report - Week of April 21, 2021
Enforcement Report - Week of March 10, 2021
CUPERTINO, Calif., Sept. 22, 2020 /PRNewswire/ -- DURECT Corporation (NASDAQ: DRRX) today announced the study design for the Phase 2b AHFIRM clinical trial of DUR-928 in severe alcoholic hepatitis (AH) patients.
Treating critically ill COVID-19 patients with corticosteroid drugs reduces the risk of death by 20%, an analysis of seven international trials found on Wednesday, prompting the World Health Organisation to update its advice on treatment.